AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2185822
Drug: Mifepristone 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 100 mg
Trial: 9745414
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy (including high dose i.v. methotrexate)
Trial: 9745414
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose i.v. methotrexate
Trial: 9745414
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (children who did not receive high dose i.v. methotrexate)
Trial: 7997610
Drug: Iopentol 350
RxNorm normalized name: iopentol 350 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopentol 350 mgI/ml
Trial: 7997610
Drug: Iopamidol 370
RxNorm normalized name: iopamidol 370 mg iodine/mL (76 %) INTRAVEN KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopamidol 370 mgI/ml
Trial: 3377206
Drug: 0.05 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg/kg lorazepam intravenously
Trial: 3377206
Drug: 1.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg secobarbital
Trial: 30864279
Drug: Soybean oil-based
RxNorm normalized name: Soybean Oil
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean oil-based parenteral lipid emulsion (PLE), n = 35
Trial: 7939369
Drug: n-3 polyunsaturated
RxNorm normalized name: Omega-3 (n-3) polyunsaturated fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 polyunsaturated fatty acids (3.4 g eicosapentaenoic and docosahexaenoic acid per day)
Trial: 10322244
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg
Trial: 21178598
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy group (240 mg lidocaine in 125 mL saline once a week for 4 weeks)
Trial: 18315472
Drug: Terazosin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (2 mg daily)
Trial: 24455735
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no medication)
Trial: 12556735
Drug: Fenoldopam (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam (a selective dopamine-1 receptor agonist)
Trial: 25833022
Drug: Idazoxan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idazoxan (40 mg)
Trial: 25012003
Drug: Perindopril 5mg
DrugBank: Perindopril (DB00790)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perindopril 5mg daily for three months prior to surgery
Trial: 25012003
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment daily for three months prior to surgery
Trial: 11607795
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor treatment
Trial: 15917842
Drug: Low-dose ghrelin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ghrelin infusion (1 pmol/kg/min)
Trial: 15917842
Drug: High-dose ghrelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ghrelin infusion (5 pmol/kg/min)
Trial: 22133776
Drug: Thalidomide 200
RxNorm normalized name: thalidomide 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide 200 mg/day
Trial: 7048770
Drug: unique dietary
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: unique dietary treatment
Trial: 28952824
Drug: Simvastatin/beta-TCP combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin/beta-TCP combination
Trial: 26787567
Drug: NAC 1200
RxNorm normalized name: NAC
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NAC 1200 mg orally before angiography and 1200 mg orally twice daily for three doses along with good hydration
Trial: 26787567
Drug: NAC 600
RxNorm normalized name: Acetylcysteine 600 MG Oral Capsule [GNC NAC 600]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NAC 600 mg before angiography and 600 mg orally twice daily for three doses plus ascorbic acid (3000 mg one dose) before angiography and 2000 mg two doses after angiography and good hydration
Trial: 26787567
Drug: Hydration with
RxNorm normalized name: Gold Bond Healing Hydration with Aloe Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydration with 0.9% saline started just before contrast media injection and continued for 12 h at a rate 1.0 mL/kg/min after angiography or 0.5 mL/kg/h in cases with overt heart failure for 12 h
Trial: 25194928
Drug: Conventional physiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physiotherapy or occupational therapy (Control)
Trial: 22244522
Drug: Tube shunt
RxNorm normalized name: Sus scrofa fallopian tube preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tube shunt (350‐mm² Baerveldt glaucoma implant)
Trial: 19584820
Drug: Glycosylated G-CSF
RxNorm normalized name: Glycosylated recombinant G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycosylated G-CSF
Trial: 9266953
Drug: Non-glycosylated G-CSF
RxNorm normalized name: Glycosylated recombinant G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-glycosylated G-CSF
Trial: 17706004
Drug: Darifenacin (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darifenacin (7.5 mg once daily for 2 weeks, then optional titration to 15 mg daily)
Trial: 17706004
Drug: Placebo (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (with sham titration)
Trial: 9929503
Drug: tizanidine HCl,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tizanidine HCl, 4 mg t.i.d. for seven consecutive doses
Trial: 9929503
Drug: both regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: both regimens simultaneously for seven consecutive doses
Trial: 11144
Drug: Cimetidine 50
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine 50 mg
Trial: 7135
Drug: Cimetidine 100
RxNorm normalized name: cimetidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 100 mg
Trial: 29945431
Drug: Sufentanil 0
RxNorm normalized name: SUFentanil 0.03 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 0 ng/mL
Trial: 19258524
Drug: Pseudoephedrine (PSE)
DrugBank: Pseudoephedrine (DB00852)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine (PSE) HCl 15 or 30 mg
Trial: 11941377
Drug: Paracetamol 600-650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 600-650 mg
Trial: 28134543
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of evaluative statements and repeated evaluative pairings (ES + REP)
Trial: 26248813
Drug: Dronabinol (5mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronabinol (5mg daily)
Trial: 3117876
Drug: Fluvoxamine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (100 mg)
Trial: 16918719
Drug: Fluvoxamine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (100 mg) and Erythromycin (1500 mg)
Trial: 25391864
Drug: 80 kV,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 kV, Iodixanol (320 mgI/ml), SAFIRE
Trial: 25391864
Drug: 80 kV,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 kV, Iopamidol (370 mgI/ml), SAFIRE
Trial: 23461283
Drug: No IOP-lowering
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No IOP-lowering medication
Trial: 7989978
Drug: Transcatheter arterial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcatheter arterial chemoembolization therapy using iodized oil (Lipiodol) before PET study
Trial: 9519022
Drug: Benzocaine spray
RxNorm normalized name: benzocaine Oral Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzocaine spray
Trial: 2742469
Drug: Air spray
RxNorm normalized name: hair spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air spray
Trial: 2774884
Drug: Placebo (air
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (air spray)
Trial: 1234015
Drug: Cardiorytmin Retard
RxNorm normalized name: diclofenac sodium Extended Release Oral Tablet [Lofensaid Retard]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiorytmin Retard (sustained-release preparation)
Trial: 1234015
Drug: Pronestyl (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pronestyl (conventional formulation)
Trial: 30815685
Drug: HCMV glycoprotein
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCMV glycoprotein B/MF59 vaccine
Trial: 26505753
Drug: Blood- plus
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood- plus liver-stage drugs (chloroquine [CQ], 3 d; artemether-lumefantrine [AL], 3 d; primaquine [PQ], 20 d, 10 mg/kg total dose)
Trial: 26505753
Drug: Blood-stage drugs
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood-stage drugs only (CQ, 3 d; AL, 3 d; placebo [PL], 20 d)
Trial: 23102821
Drug: Medication plus
RxNorm normalized name: salicylic acid Medicated Shampoo [Ionil Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication plus brief supportive psychotherapy
Trial: 18973027
Drug: Votalin sustained
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Votalin sustained released tablets
Trial: 31691133
Drug: Low-dose formulation
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose formulation
Trial: 31691133
Drug: High-dose formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose formulation
Trial: 12594878
Drug: Linezolid 600
RxNorm normalized name: linezolid 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 600 mg twice daily (intravenously or orally)
Trial: 9039837
Drug: 55 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 55 mmol/L glucose solution
Trial: 9039837
Drug: Glucose-free solution
RxNorm normalized name: glucose Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-free solution
Trial: 9039837
Drug: 110 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 110 mmol/L glucose solution
Trial: 3228775
Drug: Combination drop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination drop
Trial: 16573261
Drug: 0.75% metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% metronidazole gel
Trial: 31095868
Drug: 1-mL syringe
RxNorm normalized name: ropeginterferon alfa-2b
DrugBank: Ropeginterferon alfa-2b (DB15119)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 1-mL syringe with 30-G needle
Trial: 31095868
Drug: 3-mL syringe
RxNorm normalized name: glycopyrronium
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-mL syringe with 30-G needle
Trial: 23638141
Drug: Titration at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration at 0.5 μg/ml
Trial: 23638141
Drug: Titration at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration at 0.2 μg/ml
Trial: 23638141
Drug: Titration at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration at 0.1 μg/ml
Trial: 23638141
Drug: Induction Ce
RxNorm normalized name: Amidex ce surfactant
DrugBank: Coco diethanolamide (DB18828)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction Ce of propofol at 0.5 μg/ml
Trial: 23638141
Drug: Induction Ce
RxNorm normalized name: Amidex ce surfactant
DrugBank: Coco diethanolamide (DB18828)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction Ce of propofol at 0.2 μg/ml
Trial: 23638141
Drug: Induction Ce
RxNorm normalized name: Amidex ce surfactant
DrugBank: Coco diethanolamide (DB18828)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction Ce of propofol at 0.1 μg/ml
Trial: 26864356
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (22 g), essential amino acids (10.9 g, including 4 g leucine), and vitamin D [2.5 μg (100 IU)] with physical activity
Trial: 20814119
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 600 mg twice daily for 10 days
Trial: 17986904
Drug: 6.4% carbohydrate-electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.4% carbohydrate-electrolyte solution (CHO-E)
Trial: 12440337
Drug: Vaginal suppositoria
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal suppositoria of 100 mg Metronidazole (Arilin rapid) for 2 days
Trial: 9505164
Drug: Formula with
RxNorm normalized name: Stress B Formula with C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula with 7 g of sugar beet fiber
Trial: 2205342
Drug: Angiotensin converting
RxNorm normalized name: Angiotensin converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin converting enzyme inhibitors added to digoxin and diuretics
Trial: 293141
Drug: Plasma THC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma THC concentrations < 5.0 ng/mL
Trial: 293141
Drug: Plasma THC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma THC concentrations 5.0 to 10.0 ng/mL
Trial: 293141
Drug: Plasma THC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma THC concentrations > 10.0 ng/mL
Trial: 27973337
Drug: Intra-arterial administration
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial administration of nitroglycerine plus verapamil
Trial: 21175446
Drug: Aprepitant (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant (125 mg)
Trial: 17158228
Drug: Pravastatin (PV)
DrugBank: Pravastatin (DB00175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pravastatin (PV) + Idarubicin (Ida) + high-dose cytarabine (Ara-C)
Trial: 15150303
Drug: IP regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IP regimen (continuous portal vein infusion of 5‐fluorouracil at 500 mg/m2 daily for 7 days)
Trial: 15150303
Drug: SY regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY regimen (six 28-day courses of systemic leucovorin at 100 mg/m2 daily on days 1-5 followed by systemic bolus 5‐fluorouracil at 370 mg/m2 daily on days 1-5)
Trial: 29565716
Drug: Maltodextrin oral
RxNorm normalized name: maltodextrin ORAL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maltodextrin oral snack
Trial: 7501717
Drug: Patient-controlled medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled medication delivery
Trial: 2305603
Drug: 300 mg/day
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/day ciamexone
Trial: 28766537
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy with bortezomib for 1 year
Trial: 28766537
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy with bortezomib
Trial: 15124700
Drug: No maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No maintenance therapy (control group)
Trial: 19085578
Drug: Indacaterol 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol 200 micro g
Trial: 19085578
Drug: Indacaterol 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol 300 micro g
Trial: 19085578
Drug: Indacaterol 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol 400 micro g
Trial: 19085578
Drug: Indacaterol 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol 600 micro g
Trial: 19085578
Drug: Formoterol 12
RxNorm normalized name: formoterol 12 mcg inhalation capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 12 micro g twice daily (open-label after washout)
Trial: 1590686
Drug: Rapid infusion
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid infusion of amphotericin B (45 min)
Trial: 1590686
Drug: Slow infusion
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow infusion of amphotericin B (4 h)
Trial: 1590686
Drug: Both infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both infusion rates
Trial: 30232048
Drug: BGF MDI
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BGF MDI (budesonide/glycopyrrolate/formoterol fumarate metered‐dose inhaler 320/18/9·6 μg)
Trial: 18503906
Drug: Alteplase (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alteplase (2 mg or 4 mg based on infusion volumes of 0-50 mL or 51-100 mL, administered twice daily for 3 days)
Trial: 18503906
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution (administered twice daily for 3 days)
Trial: 15922697
Drug: Montelukast (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (10 mg once nightly)
Trial: 15922697
Drug: Fluticasone (88
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone (88 mug twice daily)
Trial: 1890517
Drug: Rectal ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal ketamine (5 mg/kg)
Trial: 1890517
Drug: Rectal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rectal midazolam (0.30 mg/kg)
Trial: 1890517
Drug: Intravenous midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous midazolam (0.05 mg/kg) after induction
Trial: 28964591
Drug: Trofinetide 35
RxNorm normalized name: Trofinetide
DrugBank: Trofinetide (DB06045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trofinetide 35 mg/kg twice daily for 14 days
Trial: 28964591
Drug: Trofinetide 35
RxNorm normalized name: Trofinetide
DrugBank: Trofinetide (DB06045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trofinetide 35 mg/kg twice daily for 28 days
Trial: 28964591
Drug: Trofinetide 70
RxNorm normalized name: Trofinetide
DrugBank: Trofinetide (DB06045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trofinetide 70 mg/kg twice daily for 28 days
Trial: 26075487
Drug: Cariprazine 3-6
RxNorm normalized name: cariprazine 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariprazine 3-6 mg/d
Trial: 25562205
Drug: Cariprazine 6-12
RxNorm normalized name: cariprazine 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariprazine 6-12 mg/d
Trial: 24227821
Drug: Weekly prophylaxis
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly prophylaxis (65 IU/kg, n = 24)
Trial: 18163065
Drug: Moving pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moving pulse magnetic field (MPMF) treatment
Trial: 11817775
Drug: Enteric-coated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated aspirin (150 mg/day)
Trial: 11817775
Drug: Plain aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain aspirin (150 mg/day)
Trial: 7822519
Drug: Calcipotriene ointment
RxNorm normalized name: Calcipotriene Ointment
DrugBank: Calcipotriol (DB02300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcipotriene ointment 0.005%
Trial: 7662599
Drug: Immediate-release diltiazem
RxNorm normalized name: diltiazem Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release diltiazem 60 mg tid
Trial: 7662599
Drug: Immediate-release diltiazem
RxNorm normalized name: diltiazem Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release diltiazem 120 mg tid
Trial: 2628313
Drug: Oral prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prostaglandin E2 tablets
Trial: 15608037
Drug: Long GnRH
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long GnRH agonist protocol
Trial: 24571886
Drug: Bimatoprost/timolol fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost/timolol fixed combination (0.03% bimatoprost and 0.5% timolol, once daily at 19:00 P.M.)
Trial: 24571886
Drug: Concurrent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent treatment (0.03% bimatoprost followed by 0.5% timolol, once daily at 19:00 P.M.)
Trial: 19855289
Drug: Bimatoprost/timolol fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost/timolol fixed combination
Trial: 10407505
Drug: Fluvastatin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin therapy
Trial: 3295315
Drug: colestipol-niacin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: colestipol-niacin therapy
Trial: 2695381
Drug: Diltiazem 120
RxNorm normalized name: diltiazem 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 120 mg t.i.d.
Trial: 6802019
Drug: Tramadol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (50 mg)